These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Shenmai injection for the treatment of cancer-related fatigue in advanced non-small cell lung cancer patients undergoing chemotherapy: study protocol for a randomized controlled trial. Zhou Y, Zhao B, Wu W, Yang X, Long S, Deng H, He W, Liao G, Li Q, Xie Z. Trials; 2018 Sep 04; 19(1):474. PubMed ID: 30180874 [Abstract] [Full Text] [Related]
3. The effect of comprehensive rehabilitation program plus chemotherapy on quality of life in patients with postoperative non-small-cell lung cancer: study protocol of a multicenter randomized clinical trial. Yao J, Jiao L, Yao Y, Lu Y, Shi J, Li J, Chen P, Xu L, Gong Y. Trials; 2020 Apr 03; 21(1):309. PubMed ID: 32245480 [Abstract] [Full Text] [Related]
4. Fuzheng Kang'ai decoction combined with gefitinib in advanced non-small cell lung cancer patients with epidermal growth factor receptor mutations: study protocol for a randomized controlled trial. Yang XB, Wu WY, Long SQ, Deng H, Pan ZQ, He WF, Zhou YS, Liao GY, Li QP, Xiao SJ, Cai JZ. Trials; 2015 Apr 10; 16():146. PubMed ID: 25873045 [Abstract] [Full Text] [Related]
6. Oral Decoctions Based on Qi-Yin Syndrome Differentiation After Adjuvant Chemotherapy in Resected Stage ΙΙΙA Non-Small Cell Lung Cancer: A Randomized Controlled Trial. Jiang Y, Liu FF, Cai YQ, Zhang P, Yang XF, Bi XY, Qin RY, Zhang S, Yin JH, Shen LP, Liu JX, Liu LS. Integr Cancer Ther; 2024 Apr 10; 23():15347354241268271. PubMed ID: 39081216 [Abstract] [Full Text] [Related]
7. A multicenter randomized controlled trial to assess the efficacy of cancer green therapy in treatment of stage IIIb/IV non-small cell lung cancer. Sun M, Zhou T, Fang X, Wang D, Pang H, Chen Y, Hu K. Medicine (Baltimore); 2020 Aug 14; 99(33):e21626. PubMed ID: 32872022 [Abstract] [Full Text] [Related]
8. [Prognostic analysis of stage III-IV non-small cell lung cancer patients treated by traditional chinese medicine]. Zhou DH, Lin LZ, Zhou YQ, Luo RC, Liu KF, Jia YJ, Chen JY, Niu XW, Su BR, Lu J, Wang ST. Ai Zheng; 2005 Oct 14; 24(10):1252-6. PubMed ID: 16219143 [Abstract] [Full Text] [Related]
9. Efficacy and safety of Jianpishengsui for chemotherapy-related fatigue in patients with non-small cell lung cancer: study protocol for a randomized placebo-controlled clinical trial. Xiao Z, Hu L, Lin J, Lu L, Huang X, Zhu X, Teo C, Lin L. Trials; 2020 Jan 16; 21(1):94. PubMed ID: 31948475 [Abstract] [Full Text] [Related]
10. Treatment of advanced non-small-cell lung cancer with Chinese herbal medicine by stages combined with chemotherapy. Xu ZY, Jin CJ, Zhou CC, Wang ZQ, Zhou WD, Deng HB, Zhang M, Su W, Cai XY. J Cancer Res Clin Oncol; 2011 Jul 16; 137(7):1117-22. PubMed ID: 21298288 [Abstract] [Full Text] [Related]
11. [Effect of traditional Chinese medicine treatment as maintenance therapy on regulating the serum concentration of sCTLA-4 in patients with advanced non-small-cell lung cancer and its relationship with prognosis]. Jiang Y, Wu LB, Shen LP, Zhang P, Jiang WJ, Tian JH, Liu LS. Zhonghua Zhong Liu Za Zhi; 2016 Oct 23; 38(10):757-762. PubMed ID: 27784460 [Abstract] [Full Text] [Related]
12. [Effects of chemotherapy combined with Chinese herbal medicine Kangliu Zengxiao decoction on tumor markers of patients with advanced non-small-cell lung cancer: a randomized, controlled trial]. Yan GY, Xu ZY, Deng HB, Wan ZY, Zhang L, Zhu JY. Zhong Xi Yi Jie He Xue Bao; 2011 May 23; 9(5):525-30. PubMed ID: 21565138 [Abstract] [Full Text] [Related]
13. Aidi injection plus platinum-based chemotherapy for stage IIIB/IV non-small cell lung cancer: A meta-analysis of 42 RCTs following the PRISMA guidelines. Wang J, Li G, Yu L, Mo T, Wu Q, Zhou Z. J Ethnopharmacol; 2018 Jul 15; 221():137-150. PubMed ID: 29655852 [Abstract] [Full Text] [Related]
15. Efficacy of traditional Chinese Medicine combined with chemotherapy in patients with non-small cell lung cancer (NSCLC): a meta-analysis of randomized clinical trials. Yang J, Zhu X, Yuan P, Liu J, Wang B, Wang G. Support Care Cancer; 2020 Aug 15; 28(8):3571-3579. PubMed ID: 32266566 [Abstract] [Full Text] [Related]
17. Assessing the effectiveness and safety of liposomal paclitaxel in combination with cisplatin as first-line chemotherapy for patients with advanced NSCLC with regional lymph-node metastasis: study protocol for a randomized controlled trial (PLC-GC trial). Hu L, Liang G, Yuliang W, Bingjing Z, Xiangdong Z, Rufu X. Trials; 2013 Feb 15; 14():45. PubMed ID: 23413951 [Abstract] [Full Text] [Related]
18. Traditional Chinese Medicine Treatment as Adjuvant Therapy in Completely Resected Stage IB-IIIA Non-Small-Cell Lung Cancer: Study Protocol for a Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial. Jiang Y, Liu LS, Shen LP, Liu JX, Jiang GN, Gu AQ, Li HC, Li Q, Li HG, Huang PX. Clin Lung Cancer; 2019 Sep 15; 20(5):e541-e547. PubMed ID: 31230892 [Abstract] [Full Text] [Related]
19. Multi-center randomized double-blind controlled clinical study of chemotherapy combined with or without traditional Chinese medicine on quality of life of postoperative non-small cell lung cancer patients. Xu L, Li H, Xu Z, Wang Z, Liu L, Tian J, Sun J, Zhou L, Yao Y, Jiao L, Su W, Guo H, Chen P, Liu J. BMC Complement Altern Med; 2012 Aug 01; 12():112. PubMed ID: 22853619 [Abstract] [Full Text] [Related]